Novara, Italy

Enrico Crestani

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Presidenza Del Consiglio Dei Ministri-Ufficio Del Ministro Per Il. Active years: 1992.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enrico Crestani: Innovator in Antibiotic Development

Introduction

Enrico Crestani is a notable inventor based in Novara, Italy. He has made significant contributions to the field of antibiotics, particularly with his innovative work on the AB-021 antibiotics. His research focuses on the cultivation of specific strains of bacteria to produce effective antibiotics that combat various pathogens.

Latest Patents

Crestani holds a patent for the AB-021 antibiotics and the process for producing them. The patent details the main components, AB-021a and AB-021b antibiotics, which are derived from the controlled aerobic cultivation of Streptomyces sp. NCIB 40068 in an aqueous nutrient cultivation medium. These antibiotics demonstrate biological activity against pathogenic fungi affecting agricultural crops, as well as human pathogenic fungi and bacteria. He has 1 patent to his name.

Career Highlights

Throughout his career, Crestani has worked with various organizations, including the Presidency of the Council of Ministers - Office of the Minister. His work has been pivotal in advancing antibiotic research and development.

Collaborations

Crestani has collaborated with notable individuals in his field, including Dante Cidaria and Nunzio Andriollo. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Enrico Crestani's innovative work in antibiotic development highlights his significant contributions to medical science. His patent for the AB-021 antibiotics showcases his commitment to addressing critical health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…